Multiplex Protein Biomarker Profiling in Patients with Familial Hypercholesterolemia
Open Access
Abstract
Familial hypercholesterolemia (FH), is an autosomal dominant disorder caused by mutations in the LDLR, APOB, PCSK9, and APOE genes and is characterized by high plasma levels of total and low-density lipoprotein (LDL) cholesterol. Our study aimed to analyze the influences of two different therapies on a wide spectrum of plasma protein biomarkers of cardiovascular diseases. Plasma from FH patients under hypolipidemic therapy (N = 18; men = 8, age 55.4 ± 13.1 years) and patients under combined long-term LDL apheresis/hypolipidemic therapy (N = 14; men = 7; age 58.0 ± 13.6 years) were analyzed in our study. We measured a profile of 184 cardiovascular disease (CVD) associated proteins using a proximity extension assay (PEA). Hypolipidemic therapy significantly (all p < 0.01) influenced 10 plasma proteins (TM, DKK1, CCL3, CD4, PDGF subunit B, AGRP, IL18, THPO, and LOX1 decreased; ST2 increased). Under combined apheresis/hypolipidemic treatment, 18 plasma proteins (LDLR, PCSK9, MMP-3, GDF2, CTRC, SORT1, VEGFD, IL27, CCL24, and KIM1 decreased; OPN, COL1A1, KLK6, IL4RA, PLC, TNFR1, GLO1, and PTX3 increased) were significantly affected (all p < 0.006). Hypolipidemic treatment mainly affected biomarkers involved in vascular endothelial maintenance. Combined therapy influenced proteins that participate in cholesterol metabolism and inflammation.Keywords
Funding Information
- Ministerstvo Zdravotnictví Ceské Republiky (NU22-01-00151, MH CZ - DRO IN 00023001)
- Charles University, Faculty of Medicine in Hradec Kralove (PROGRES Q40/12)
This publication has 45 references indexed in Scilit:
- LDL-Apheresis: Technical and Clinical AspectsThe Scientific World Journal, 2012
- The IL-33/ST2 pathway — A new therapeutic target in cardiovascular diseasePharmacology & Therapeutics, 2011
- Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human bloodNucleic Acids Research, 2011
- Vascular endothelial growth factor-D is overexpressed in human cardiac allograft vasculopathy and diabetic atherosclerosis and induces endothelial permeability to low-density lipoproteins in vitroThe Journal of Heart and Lung Transplantation, 2011
- Functional Role of Kallikrein 6 in Regulating Immune Cell SurvivalPLOS ONE, 2011
- A Novel Biomarker of Coronary Atherosclerosis: Serum DKK1 Concentration Correlates with Coronary Artery Calcification and Atherosclerotic PlaquesJournal of Korean Medical Science, 2011
- Expression of Tumor Necrosis Factor Receptor-1 in Arterial Wall Cells Promotes AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6Atherosclerosis, 2006
- Cross-sectional association of soluble thrombomodulin with mild peripheral artery disease; the ARIC studyAtherosclerosis, 2001
- Thrombopoietin and mean platelet volume in coronary artery diseaseClinical Cardiology, 2001